
In today’s ACT Brief, we examine what drives inconsistent oncology trial screening, why FDA has reportedly paused its priority voucher pilot, and how patients’ use of AI is reshaping how sponsors communicate with them.
Key challenges and strategies to consider when developing devices intended for home-use or deployment in a clinical research setting.






